Investor Presentation

RNS Number : 0005I
RUA Life Sciences PLC
30 November 2022
 

30 November 2022

 

RUA Life Sciences Plc

("RUA Life Sciences", the "Company" or the "Group")

Investor Presentation - 12 December 2022

 

RUA Life Sciences plc (AIM: RUA.L), the holding company of a group of medical device businesses focused on the exploitation of the world leading long-term implantable biostable polyurethane (Elast- Eon™), is pleased to announce they will conduct an Investor Presentation which will follow the publication of the Group's interim results for the six-month period ended 30 September 2022.

 

The event will take place at 11.00am on Monday 12 December with Bill Brown (Chairman) and Caroline Stretton (Managing Director) presenting from the company.

The online presentation is open to all existing and potential shareholders. Questions can be submitted during the presentation to be addressed at the end.


To register for the event, please click
here .

A recording of the presentation will be available shortly afterwards
here .


For more information please contact:

Equity Development 
Hannah Crowe / Matt Evans
020 7065 2692

 

 


 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAPPGPWGUPPPGB
UK 100